Moffitt Cancer Center
Tampa, FL USA
Add to Favorites | Newsroom RSS | Share

Our News on Newswise

Moffitt Cancer Center Researchers Discover Liver Metastases have Different Radiation Sensitivities Based on Primary Tumor Histology

TAMPA, Fla. – Radiation is a commonly used therapeutic option to treat liver metastases, with the majority of tumors maintained under control after one year. However, some patients do not respond as well to radiation treatment, and the factors...
12-Apr-2016 4:05 PM EDT Add to Favorites

Histone Deacetylase Inhibitors Enhance Immunotherapy in Lung Cancer Models, Say Moffitt Cancer Center Researchers

TAMPA, Fla. – Several new immunotherapeutic antibodies that inhibit checkpoint receptors on T cells to restimulate the immune system to target tumors have been approved to treat advanced stage lung cancer and melanoma; however, only 20 percent of...
31-Mar-2016 2:05 PM EDT Add to Favorites

Moffitt Pathologists Identify New Potential Target in Ovarian Serous Cancer

TAMPA, Fla. – Moffitt Cancer Center researchers discovered that patients with ovarian serous cancer and an overexpression of the HER4 protein are less likely to respond to chemotherapy and have a lower rate of survival. That’s according to a...
18-Mar-2016 12:05 PM EDT Add to Favorites

Neutralizing a Tumor’s Acidic Environment Improves Activity of Immune-Targeting Cancer Therapies

Cancer cells have the ability to grow in an acidic tumor environment that is detrimental to other cells, including immune cells. In a Cancer Research cover article published this week, Moffitt Cancer Center reported that neutralizing the acidic...
17-Mar-2016 10:05 AM EDT Add to Favorites

Moffitt Cancer Center Researchers Target Specific Protein Associated with Poor Survival and Treatment Resistance in Brain Cancer Patients

TAMPA, Fla. – Glioblastoma multiforme (GBM) is a highly aggressive brain tumor with low survival rates, with newly diagnosed patients surviving a median of 14 months and recurrent patients surviving a median of only 3 to 9 months. New therapeutic...
4-Mar-2016 9:05 AM EST Add to Favorites

Moffitt Cancer Center’s Dr. Said Sebti Receives National Cancer Institute Outstanding Investigator Award

TAMPA, Fla. – Said M. Sebti, Ph.D., chair of the Drug Discovery Department and co-leader of the Chemical Biology and Molecular Medicine Program at Moffitt Cancer Center, has been awarded an Outstanding Investigator Award from the National Cancer...
1-Mar-2016 4:05 PM EST Add to Favorites

Moffitt Cancer Center Receives GMaP Grant to Strengthen, Promote Cancer Health Disparities Research and Training

TAMPA, Fla. – Moffitt Cancer Center received a grant from the National Cancer Institute Center to Reduce Cancer Health Disparities to bring together researchers, trainees, new and early-stage investigators, and community health members to...
25-Feb-2016 10:05 AM EST Add to Favorites

Moffitt Develops Novel Cancer Treatment Based on Evolutionary Principals to Inhibit Chemo-Resistance, Prolong Progression-Free Survival

Despite numerous advances in oncology since the War on Cancer began, many patients develop resistance to standard therapies and eventually relapse. Moffitt Cancer Center researchers hope to improve treatment outcomes with development of a novel...
24-Feb-2016 2:05 PM EST Add to Favorites

Our Experts on Newswise

Our experts are coming soon...

Our YouTube Videos